Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Registry Study for Talimogene Laherparepvec (NCT02173171) | Amgen | 2010-04-27 |
Track Any Tumor Type Eligible for Treatment With Talimogene Laherparepvec in Amgen or BioVEX-sponsored Clinical Trial automatically
Every clearance here is in the API, with alerts when new ones post.